Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patient death
Pharma
Amgen submits analyses to FDA in bid for Tavneos hearing
With all eyes on Tavneos’ seemingly precarious approval status in the U.S., Amgen is advancing plans to defend the ANCA-associated vasculitis drug.
Fraiser Kansteiner
Jul 24, 2026 10:50am
Pfizer confirms patient death in hemophilia drug trial
Dec 23, 2025 11:05am
FDA probes safety of Takeda's Adzynma after reported death
Nov 21, 2025 11:40am
Untangling Sarepta’s gene therapy fallout
Aug 1, 2025 9:07am
FDA backtracks on Sarepta's gene therapy Elevidys in DMD
Jul 28, 2025 6:02pm
FDA eyeing study requirements to confirm Elevidys safety: report
Jul 24, 2025 3:12pm
